Skip to main content
. 2023 Mar 12;24(6):5413. doi: 10.3390/ijms24065413

Figure 3.

Figure 3

Figure 3

Effect of CPSP and melatonin treatment on mitochondria chain complexes, including (A) mitochondrial complex-i (NADH: ubiquinone oxidoreductase; n = 5, per group), (B) complex-ii (n = 4, per group), (C) complex-iii (n = 5, per group), and (D) complex-iv (n = 5, per group) levels in the thalamus and cortex after two weeks of melatonin administration. Data expressed as mean ± SD; * p < 0.005 as compared with CPSP.